Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy forHelicobacter pylori—authors’ reply
Y. S. Jung; E. H. Kim; C. H. Park
Author Information: Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.